ARVINAS, INC. (ARVN) Debt Components
- 2026-06-30: Long-term Debt, Current MaturitiesUSD $200.00K; Long-term Debt, Excluding Current MaturitiesUSD $300.00K; Long-term DebtUSD $500.00K; Long-Term Debt, Maturity, Year OneUSD $200.00K.
- 2026-03-31: Long-term Debt, Current MaturitiesUSD $200.00K; Long-term Debt, Excluding Current MaturitiesUSD $300.00K; Long-term DebtUSD $500.00K; Long-Term Debt, Maturity, Year OneUSD $200.00K.
- 2025-12-31: Long-term Debt, Current MaturitiesUSD $200.00K; Long-term Debt, Excluding Current MaturitiesUSD $400.00K; Long-term DebtUSD $600.00K; Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD $200.00K.
ARVINAS, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Debt Instrument, Interest Rate, Stated Percentage pure | Long-Term Debt, Maturity, Year Five USD | Long-Term Debt, Maturity, after Year Five USD | Debt Instrument, Unamortized Discount USD | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $200.00K | $300.00K | $500.00K | $200.00K | $200.00K | (m) | (m) | $100.00K | 3.25% | (m) | (m) | (m) | (m) |
| 2026-03-31 | $200.00K | $300.00K | $500.00K | $200.00K | $200.00K | (m) | (m) | $100.00K | 3.25% | (m) | (m) | (m) | (m) |
| 2025-12-31 | $200.00K | $400.00K | $600.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | (m) | (m) | $200.00K | $200.00K | $200.00K | (m) | (m) | 3.25% | (m) | (m) | (m) | (m) |
| 2025-09-30 | $200.00K | $400.00K | $600.00K | $200.00K | $200.00K | $200.00K | (m) | $0.00 | 3.25% | (m) | (m) | (m) | (m) |
| 2025-06-30 | $200.00K | $500.00K | $700.00K | $200.00K | $200.00K | $200.00K | (m) | $100.00K | 3.25% | (m) | (m) | (m) | (m) |
| 2025-03-31 | $200.00K | $500.00K | $700.00K | $200.00K | $200.00K | $200.00K | (m) | $100.00K | 3.25% | (m) | (m) | (m) | (m) |
| 2024-12-31 | $200.00K | $600.00K | $800.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | (m) | $200.00K | $200.00K | $200.00K | $200.00K | (m) | 3.25% | (m) | (m) | (m) | (m) |
| 2024-09-30 | $200.00K | $600.00K | $800.00K | $200.00K | $200.00K | $200.00K | $200.00K | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $200.00K | $700.00K | $900.00K | $200.00K | $200.00K | $200.00K | $200.00K | $100.00K | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $200.00K | $700.00K | $900.00K | $200.00K | $200.00K | $200.00K | $200.00K | $100.00K | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $200.00K | $800.00K | $1.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | $200.00K | $200.00K | $200.00K | $200.00K | (m) | (m) | $200.00K | (m) | (m) | (m) |
| 2023-09-30 | $200.00K | $800.00K | $1.00M | $0.00 | $200.00K | $200.00K | $200.00K | (m) | (m) | $200.00K | (m) | (m) | (m) |
| 2023-06-30 | $100.00K | $900.00K | $1.00M | $0.00 | $200.00K | $200.00K | $200.00K | (m) | (m) | $200.00K | (m) | (m) | (m) |
| 2023-03-31 | $100.00K | $900.00K | $1.00M | $0.00 | $200.00K | $200.00K | $200.00K | (m) | (m) | $200.00K | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | $1.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | $1.00M | $0.00 | $200.00K | $200.00K | $200.00K | (m) | (m) | $200.00K | $200.00K | (m) | (m) |
| 2022-09-30 | (m) | $1.00M | $1.00M | $0.00 | $200.00K | $200.00K | $200.00K | (m) | (m) | $200.00K | (m) | (m) | (m) |
| 2022-06-30 | (m) | $1.00M | $1.00M | $0.00 | $200.00K | $200.00K | $200.00K | (m) | (m) | $200.00K | (m) | (m) | (m) |
| 2022-03-31 | (m) | $1.00M | $1.00M | $0.00 | $200.00K | $200.00K | $200.00K | (m) | (m) | $200.00K | (m) | (m) | (m) |
| 2021-12-31 | (m) | $1.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | $1.00M | (m) | $0.00 | $200.00K | $200.00K | (m) | (m) | $200.00K | $400.00K | (m) | (m) |
| 2021-09-30 | (m) | $1.00M | $1.00M | (m) | $46.24K | $188.76K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $1.00M | $1.00M | (m) | $46.24K | $188.76K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $2.00M | $2.00M | (m) | $92.48K | $377.52K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $2.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | $2.00M | (m) | (m) | $92.48K | $377.52K | (m) | (m) | $389.97K | $1.14M | (m) | (m) |
| 2020-09-30 | (m) | $2.00M | $2.00M | (m) | (m) | (m) | (m) | (m) | (m) | $92.48K | (m) | (m) | (m) |
| 2020-06-30 | (m) | $2.00M | $2.00M | (m) | (m) | (m) | (m) | (m) | (m) | $92.48K | (m) | (m) | (m) |
| 2020-03-31 | (m) | $2.00M | $2.00M | (m) | (m) | (m) | (m) | (m) | (m) | $92.48K | (m) | (m) | (m) |
| 2019-12-31 | (m) | $2.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | $2.00M | (m) | (m) | (m) | $92.48K | (m) | (m) | $377.52K | $1.53M | (m) | (m) |
| 2019-09-30 | (m) | $2.00M | $2.00M | (m) | (m) | (m) | (m) | (m) | (m) | $92.48K | (m) | (m) | (m) |
| 2019-06-30 | $71.50K | $2.00M | $2.08M | (m) | (m) | (m) | (m) | $77.67K | (m) | $92.48K | (m) | $1.03K | (m) |
| 2019-03-31 | $113.41K | $2.00M | $2.12M | (m) | (m) | (m) | (m) | $124.07K | (m) | $92.48K | (m) | $4.12K | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $7.21K | (m) |
| 2018-12-31 | $154.46K | $2.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | $2.17M | $169.61K | (m) | (m) | (m) | (m) | (m) | $92.48K | $1.91M | (m) | $7.21K |
| 2018-09-30 | $194.67K | $2.00M | $2.21M | (m) | $184.60K | (m) | (m) | $29.71K | (m) | (m) | $2.00M | $10.30K | $10.30K |
| 2017-12-31 | $159.26K | $151.12K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $19.57K | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |